[go: up one dir, main page]

RU98113304A - NEW PHOSPHOLIPID DERIVATIVES OF PHOSPHONOCARBOXYLIC ACIDS, THEIR PRODUCTION AND APPLICATION AS ANTI-VIRUS MEDICINES - Google Patents

NEW PHOSPHOLIPID DERIVATIVES OF PHOSPHONOCARBOXYLIC ACIDS, THEIR PRODUCTION AND APPLICATION AS ANTI-VIRUS MEDICINES

Info

Publication number
RU98113304A
RU98113304A RU98113304/04A RU98113304A RU98113304A RU 98113304 A RU98113304 A RU 98113304A RU 98113304/04 A RU98113304/04 A RU 98113304/04A RU 98113304 A RU98113304 A RU 98113304A RU 98113304 A RU98113304 A RU 98113304A
Authority
RU
Russia
Prior art keywords
formula
compounds
butyl
denotes
benzyl
Prior art date
Application number
RU98113304/04A
Other languages
Russian (ru)
Other versions
RU2166508C2 (en
Inventor
Цильх Харальд
Херрманн Дитер
Опитц Ханс-Георг
Циммерманн Герд
Original Assignee
Роше Диагностикс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1995147023 external-priority patent/DE19547023A1/en
Priority claimed from DE1996143416 external-priority patent/DE19643416A1/en
Application filed by Роше Диагностикс Гмбх filed Critical Роше Диагностикс Гмбх
Publication of RU98113304A publication Critical patent/RU98113304A/en
Application granted granted Critical
Publication of RU2166508C2 publication Critical patent/RU2166508C2/en

Links

Claims (8)

1. Новые фосфолипидные производные фосфонокарбоновых кислот общей формулы I
Figure 00000001

в которой R1 обозначает линейную или разветвленную, насыщенную или ненасыщенную алкильную цепь с 9-13 атомами углерода;
R2 обозначает линейную или разветвленную, насыщенную или ненасыщенную алкильную цепь с 8-12 атомами углepoдa;
R3 обозначает Н, линейную или разветвленную алкильную цепь с 1-6 атомами углерода, в частности, метил, этил, пропил, изопропил, бутил, изобутил, трет-бутил, пентил, гексил, неопентил, тексил или фенил, холин, этаноламин, карнитин, С57-циклоалкил, бензил или одну из следующих групп
Figure 00000002

Figure 00000003

Figure 00000004

причем R4 обозначает алкил, бензил или фенил и R5, и R6 обозначают алкил и п равно 1, 2 или 3;
n равно 0, 1 или 2;
m равно 0, соответственно 1-3;
их таутомеры, оптические изомеры, рацематы, их пролекарства и их физиологически приемлемые соли неорганических и органических оснований.
1. New phospholipid derivatives of phosphonocarboxylic acids of General formula I
Figure 00000001

in which R 1 denotes a linear or branched, saturated or unsaturated alkyl chain with 9-13 carbon atoms;
R 2 is a linear or branched, saturated or unsaturated alkyl chain with 8-12 carbon atoms;
R 3 is H, a linear or branched alkyl chain with 1-6 carbon atoms, in particular methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, hexyl, neopentyl, texyl or phenyl, choline, ethanolamine, carnitine, C 5 -C 7 cycloalkyl, benzyl or one of the following groups
Figure 00000002

Figure 00000003

Figure 00000004

wherein R 4 is alkyl, benzyl or phenyl and R 5 and R 6 are alkyl and n is 1, 2 or 3;
n is 0, 1 or 2;
m is 0, respectively 1-3;
their tautomers, optical isomers, racemates, their prodrugs and their physiologically acceptable salts of inorganic and organic bases.
2. Соединения формулы I по п.1, в которых R1 обозначает децильную, ундецильную, додецильную или тридецильную группу.2. The compounds of formula I according to claim 1, in which R 1 denotes a decyl, undecyl, dodecyl or tridecyl group. 3. Соединения формулы I по одному из п.1 или 2, в которых R2 обозначает децильную, ундецильную или додецильную группу.3. The compounds of formula I according to one of claim 1 or 2, in which R 2 denotes a decyl, undecyl or dodecyl group. 4. Соединения формулы I по одному из пп.1-3, в которых n равно 0 или 1. 4. The compounds of formula I according to one of claims 1 to 3, in which n is 0 or 1. 5. Соединения формулы I по одному из пп.1-4, в которых m равно 0,1 или 2. 5. The compounds of formula I according to one of claims 1 to 4, in which m is 0.1 or 2. 6. Соединения формулы I по одному из пп.1-5, в которых R3 обозначает метил, этил, пропил, бутил, трет-бутил или бензил.6. The compounds of formula I according to one of claims 1 to 5, in which R 3 denotes methyl, ethyl, propyl, butyl, tert-butyl or benzyl. 7. Лекарственное средство, содержащее по меньшей мере одно соединение формулы I по одному из пп.1-6 наряду с обычными фармацевтическими вспомогательными веществами и носителями. 7. A medicine containing at least one compound of formula I according to one of claims 1 to 6, along with conventional pharmaceutical excipients and carriers. 8. Применение по меньшей мере одного соединения общей формулы I по одному из пп. 1-6 для получения медикамента для лечения аутоиммунных болезней, новообразований, воспалительных, вирусных или ретровирусных заболеваний. 8. The use of at least one compound of general formula I according to one of claims. 1-6 to obtain a medication for the treatment of autoimmune diseases, neoplasms, inflammatory, viral or retroviral diseases.
RU98113304/04A 1995-12-15 1996-12-16 Phosphonolipids of carboxylic acids and salts thereof, and antiviral agent based thereon RU2166508C2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19547023.0 1995-12-15
DE1995147023 DE19547023A1 (en) 1995-12-15 1995-12-15 New phosphatidyl alkanoic acid derivatives
DE19643416.5 1996-10-22
DE1996143416 DE19643416A1 (en) 1996-10-22 1996-10-22 New phospho:lipid derived from phosphono-carboxylate and thio-glycerol

Publications (2)

Publication Number Publication Date
RU98113304A true RU98113304A (en) 2000-04-27
RU2166508C2 RU2166508C2 (en) 2001-05-10

Family

ID=26021319

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98113304/04A RU2166508C2 (en) 1995-12-15 1996-12-16 Phosphonolipids of carboxylic acids and salts thereof, and antiviral agent based thereon

Country Status (23)

Country Link
US (1) US6136797A (en)
EP (1) EP0868425B1 (en)
JP (1) JP2000515113A (en)
KR (1) KR20000064374A (en)
CN (1) CN1085672C (en)
AR (1) AR005089A1 (en)
AT (1) ATE278698T1 (en)
AU (1) AU714236B2 (en)
BR (1) BR9612133A (en)
CA (1) CA2240366A1 (en)
CZ (1) CZ291823B6 (en)
DE (1) DE59611111D1 (en)
ES (1) ES2230574T3 (en)
HU (1) HUP0001534A3 (en)
IL (1) IL124790A (en)
NO (1) NO982754L (en)
NZ (1) NZ325259A (en)
PL (1) PL186402B1 (en)
RU (1) RU2166508C2 (en)
SK (1) SK75698A3 (en)
TR (1) TR199801082T2 (en)
TW (1) TW343975B (en)
WO (1) WO1997022613A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19547022A1 (en) * 1995-12-15 1997-06-19 Boehringer Mannheim Gmbh Covalent lipid-phosphonocarboxylic acid conjugates, their preparation and their use as antiviral drugs
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
US20040006242A1 (en) 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
US6835721B2 (en) 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
US6551600B2 (en) * 1999-02-01 2003-04-22 Eisai Co., Ltd. Immunological adjuvant compounds compositions and methods of use thereof
US6818057B2 (en) 1999-03-02 2004-11-16 Construction Research & Technology Gmbh Retarder for calcium sulfoaluminate cements
RU2265439C2 (en) * 2000-01-04 2005-12-10 Де Риджентс Ов Де Юниверсити Ов Калифорния Treatment of hiv infection at medicinal resistance
RU2240792C2 (en) * 2002-07-30 2004-11-27 Государственное учреждение Научно-исследовательский институт вирусологии им. Д.И. Ивановского РАМН Combinations based on netropsin or its bis-derivative eliciting anti-herpetic activity
US20040172288A1 (en) * 2003-02-27 2004-09-02 Korn Lawrence D. Method for disseminating medical alert information
WO2006116423A2 (en) 2005-04-26 2006-11-02 Eisai Co., Ltd Compositions and methods for cancer immunotherapy
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
JP5752599B2 (en) * 2008-11-06 2015-07-22 ヴァスキュラー バイオジェニックス リミテッド Oxidized lipid compounds and uses thereof
EP2876094A1 (en) 2014-04-03 2015-05-27 Basf Se Cement and calcium sulphate based binder composition
KR101658048B1 (en) 2014-06-25 2016-09-20 한국생명공학연구원 Anti-viral composition comprising compounds related to phosphatidylcholine synthetic pathway
EP3813839A4 (en) * 2018-06-26 2022-07-20 TSRL, Inc. METABOLICLY STABLE PRODRUGS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3164332D1 (en) * 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
DE3929217A1 (en) * 1989-09-02 1991-03-07 Boehringer Mannheim Gmbh USE OF PHOSPHOLIPID DERIVATIVES AS ANTIVIRAL MEDICINAL PRODUCTS AND NEW PHOSPHOLIPIDES
DE4026265A1 (en) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh NEW PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES, THEIR PRODUCTION AND THEIR USE AS ANTIVIRAL MEDICINAL PRODUCTS
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
DE19547022A1 (en) * 1995-12-15 1997-06-19 Boehringer Mannheim Gmbh Covalent lipid-phosphonocarboxylic acid conjugates, their preparation and their use as antiviral drugs

Similar Documents

Publication Publication Date Title
RU98113304A (en) NEW PHOSPHOLIPID DERIVATIVES OF PHOSPHONOCARBOXYLIC ACIDS, THEIR PRODUCTION AND APPLICATION AS ANTI-VIRUS MEDICINES
FR2658818B1 (en) NOVEL DERIVATIVES WITH NAPHTHALENIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ATE28872T1 (en) NEW IMIDAZOLE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
KR960007545A (en) Synthetic excitatory amino acids
KR960703580A (en) Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
RU2002101723A (en) INDANYL SUBSTITUTED BENZENE CARBONAMIDES, METHOD FOR PRODUCING THEM, THEIR USE AS A MEDICINAL PRODUCT, AND ALSO CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
RU93005057A (en) PHARMACEUTICAL COMPOUNDS, THYENOBENZODIAZEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION, PHARMOCOMPOSITION AND THEIR USE
RU95117068A (en) ANTIHYPERTRIGLICYRIDEMIC COMPOSITION, METHOD FOR PRODUCING IT, METHOD FOR TREATING OR PREVENTION OF HYPERTRIGLYCERIDEMIA, USE OF COMPOUNDS
RU96112152A (en) DIHYDROPYRIDINE SHORT-TERM ACTION, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
AR007759A1 (en) NEW HETERO CYCLIC COMPOUNDS, THE USE OF THE SAME TO PREPARE PHARMACEUTICAL COMPOSITIONS, A PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM.
RU94045278A (en) Use of 2-phenyl-3-aroylbenzothiophenes for vasomotor symptom and associated psychological disorder inhibition associated with postclimacteric syndrome
DK0534445T3 (en) Process for the preparation of a medicament for oral or topical administration in the treatment of Leishmaniasis
EA200000792A2 (en) Pyridine compounds, a process for their preparation and pharmaceutical compositions containing them
ES2130472T3 (en) GUANIDIDES OF ALKENYL CARBOXYLLIC ACIDS SUBSTITUTED WITH PHENYL, CARRIERS OF PERFLUORO-ALKYL GROUPS, PROCEDURE FOR THEIR PREPARATION, USE AS A MEDICINAL PRODUCT OR DIAGNOSTIC AGENT, AS WELL AS A DRUG CONTAINING THEM.
SE8205870L (en) NEW PRODUCTS 3-AMINO-2-OXO-AZETIDINE-1-SULPHONIC ACID DERIVATIVES, SET FOR MANUFACTURING THEREOF, USING IT AS A MEDICINAL PRODUCT, COMPOSITIONS CONTAINING THEM AND RECEIVING NEW INTERMEDIATE PRODUCTS
AR005089A1 (en) DERIVATIVES OF PHOSPHOLIPIDS FROM PHOSPHONOCARBOXILIC ACIDS, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
RU96123227A (en) AMIDIC DERIVATIVES AND THEIR THERAPEUTIC USE
KR910000607A (en) New ester
RU97103140A (en) NEW 3-SUBSTITUTED 3H-2,3-BENZODIAZEPINE DERIVATIVES, THEIR PRODUCTION AND APPLICATION AS MEDICINES
RU97108129A (en) NITROBENZAMIDES APPLICABLE AS ANTIARRHYTHMIC MEDICINES
RU93053036A (en) α, ω -DIRYLALKANE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE INDICATED DERIVATIVES
RU94021366A (en) New alicyclic compounds inhibiting phospholipase, their salts, method of synthesis, pharmaceutical composition and treatment method
EA200000374A2 (en) New 2,3-methano-amino acid compounds, a process for their preparation and pharmaceutical compositions containing them
SE8800846L (en) OPTICALLY ACTIVE OXO-ISOINDOLIN DERIVATIVES
AR004513A1 (en) HETERO CYCLIC COMPOUNDS, METHOD FOR PREPARING THEM, USE THEMSELVES FOR PREPARING MEDICINES AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM